LONDON: Oxford’s Covid-19 vaccine candidate has a better immune response when using a two full dose regimen rather than a full dose followed by a half-dose booster dose, the university said Thursday. The candidate vaccine, which has been licensed to AstraZeneca, has published the results of an interim late-stage trial …
Read More »
LONDON: Oxford’s Covid-19 vaccine candidate has a better immune response when using a two full dose regimen rather than a full dose followed by a half-dose booster dose, the university said Thursday. The candidate vaccine, which has been licensed to AstraZeneca, has published the results of an interim late-stage trial …
Read More »
NEW DELHI: No vaccine for respiratory diseases it is 100% effective and those that are 50-100% effective can be approved for use against the Covid-19 pandemic, Indian Council of Medical Research (ICMR), Dr. Balram Bhargava, CEO, said even when adding that maximum efficacy will be sought. “No vaccine for respiratory …
Read More »